A citation-based method for searching scientific literature

Myriam Sasanelli, Michel Meignan, Corinne Haioun, Alina Berriolo-Riedinger, René-Olivier Casasnovas, Alberto Biggi, Andrea Gallamini, Barry A Siegel, Amanda F Cashen, Pierre Véra, Hervé Tilly, Annibale Versari, Emmanuel Itti. Eur J Nucl Med Mol Imaging 2014
Times Cited: 124







List of co-cited articles
599 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.
N George Mikhaeel, Daniel Smith, Joel T Dunn, Michael Phillips, Henrik Møller, Paul A Fields, David Wrench, Sally F Barrington. Eur J Nucl Med Mol Imaging 2016
143
50

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
45

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
Anne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, Michel Meignan, Pierre Vera, Hervé Tilly, Fabrice Jardin, Stéphanie Becker. Clin Cancer Res 2016
101
45

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, Michel Meignan, Martin Hutchings, Stefan P Müeller, Lawrence H Schwartz, Emanuele Zucca, Richard I Fisher, Judith Trotman,[...]. J Clin Oncol 2014
829
44

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Ronald Boellaard, Roberto Delgado-Bolton, Wim J G Oyen, Francesco Giammarile, Klaus Tatsch, Wolfgang Eschner, Fred J Verzijlbergen, Sally F Barrington, Lucy C Pike, Wolfgang A Weber,[...]. Eur J Nucl Med Mol Imaging 2015
36

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.
Michel Meignan, Anne Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis, Sami Boussetta, Ilaria Grassi, René-Olivier Casasnovas, Corinne Haioun, Hervé Tilly,[...]. J Clin Oncol 2016
156
34

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.
Michel Meignan, Myriam Sasanelli, René Olivier Casasnovas, Stefano Luminari, Federica Fioroni, Chiara Coriani, Helene Masset, Emmanuel Itti, Paolo G Gobbi, Francesco Merli,[...]. Eur J Nucl Med Mol Imaging 2014
103
34

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement.
Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Sang-Min Lee, Su-Ee Lee, Ho-Sup Lee, Gyeong-Won Lee, Seong-Jang Kim, Seok-Mo Lee, Dong-Seop Chung. Ann Hematol 2012
95
32


Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
Mathieu Nessim Toledano, P Desbordes, A Banjar, I Gardin, P Vera, P Ruminy, F Jardin, H Tilly, S Becker. Eur J Nucl Med Mol Imaging 2018
45
64

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.
Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Alexandre Cochet, Olivier Humbert, Michel Toubeau, Emmanuelle Ferrant, François Brunotte, René-Olivier Casasnovas. Eur J Nucl Med Mol Imaging 2014
96
28

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
Zheng Zhou, Laurie H Sehn, Alfred W Rademaker, Leo I Gordon, Ann S Lacasce, Allison Crosby-Thompson, Ann Vanderplas, Andrew D Zelenetz, Gregory A Abel, Maria A Rodriguez,[...]. Blood 2014
489
27

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
Hajira Ilyas, N George Mikhaeel, Joel T Dunn, Fareen Rahman, Henrik Møller, Daniel Smith, Sally F Barrington. Eur J Nucl Med Mol Imaging 2018
64
42

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
900
23

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J M Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini,[...]. Blood 2015
94
23

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Anne-Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, Antonio Castagnoli, Pauline Brice, John Raemaekers,[...]. Blood 2018
75
28

Revised response criteria for malignant lymphoma.
Bruce D Cheson, Beate Pfistner, Malik E Juweid, Randy D Gascoyne, Lena Specht, Sandra J Horning, Bertrand Coiffier, Richard I Fisher, Anton Hagenbeek, Emanuele Zucca,[...]. J Clin Oncol 2007
20

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
Tae Min Kim, Jin Chul Paeng, In Kook Chun, Bhumsuk Keam, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Dong Soo Lee, Chul Woo Kim, June-Key Chung,[...]. Cancer 2013
104
20

Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.
Qaid Ahmed Shagera, Gi Jeong Cheon, Youngil Koh, Min Young Yoo, Keon Wook Kang, Dong Soo Lee, E Edmund Kim, Sung-Soo Yoon, June-Key Chung. Eur J Nucl Med Mol Imaging 2019
29
68

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
19

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).
A S Cottereau, S Becker, F Broussais, O Casasnovas, S Kanoun, M Roques, N Charrier, S Bertrand, R Delarue, C Bonnet,[...]. Ann Oncol 2016
57
31


Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Hugo J A Adams, John M H de Klerk, Rob Fijnheer, Ben G F Heggelman, Stefan V Dubois, Rutger A J Nievelstein, Thomas C Kwee. Eur J Haematol 2015
43
39

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, Alberto Biggi, Amanda F Cashen, Pierre Véra, Hervé Tilly, Barry A Siegel, Andrea Gallamini, René-Olivier Casasnovas,[...]. Eur J Nucl Med Mol Imaging 2013
162
16

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Alison J Moskowitz, Heiko Schöder, Somali Gavane, Katie L Thoren, Martin Fleisher, Joachim Yahalom, Susan J McCall, Briana R Cadzin, Stephanie Y Fox, John Gerecitano,[...]. Blood 2017
69
21

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
Ulrich Dührsen, Stefan Müller, Bernd Hertenstein, Henrike Thomssen, Jörg Kotzerke, Rolf Mesters, Wolfgang E Berdel, Christiane Franzius, Frank Kroschinsky, Matthias Weckesser,[...]. J Clin Oncol 2018
94
15

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
649
15

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, Christoph Renner, Thomas Pabst, Christoph Driessen, Ulrich Mey, Miklos Pless, Mario Bargetzi, Fatime Krasniqi,[...]. J Clin Oncol 2015
117
14

Metabolic Tumor Volume Metrics in Lymphoma.
Lale Kostakoglu, Stéphane Chauvie. Semin Nucl Med 2018
48
29

F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.
Rosj Gallicchio, Giovanna Mansueto, Vittorio Simeon, Anna Nardelli, Roberto Guariglia, Daniela Capacchione, Ernesto Soscia, Piernicola Pedicini, Domenico Gattozzi, Pellegrino Musto,[...]. Eur J Haematol 2014
54
25

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma.
Salim Kanoun, Ilan Tal, Alina Berriolo-Riedinger, Cédric Rossi, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Louis Legrand, Olivier Humbert, Olivier Casasnovas, François Brunotte,[...]. PLoS One 2015
64
21

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
749
14


High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loic Chartier, Christophe Fruchart, Louise Roulin, Lucie Oberic, Gian Matteo Pica,[...]. Blood 2020
39
35

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.
Michel Meignan, Andrea Gallamini, Michel Meignan, Andrea Gallamini, Corinne Haioun. Leuk Lymphoma 2009
455
13

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
13

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report.
Mira Tout, Olivier Casasnovas, Michel Meignan, Thierry Lamy, Franck Morschhauser, Gilles Salles, Emmanuel Gyan, Corinne Haioun, Mélanie Mercier, Pierre Feugier,[...]. Blood 2017
56
23



Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
Anne-Ségolène Cottereau, Sebastien Hapdey, Loic Chartier, Romain Modzelewski, Olivier Casasnovas, Emmanuel Itti, Herve Tilly, Pierre Vera, Michel A Meignan, Stéphanie Becker. J Nucl Med 2017
36
36

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.
Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga, Martin Moorhead, Francois Pepin, Katherine Kong, Margaret Shovlin, Elaine S Jaffe, Louis M Staudt, Catherine Lai,[...]. Lancet Oncol 2015
238
13

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
David M Kurtz, Michael R Green, Scott V Bratman, Florian Scherer, Chih Long Liu, Christian A Kunder, Kazuhiro Takahashi, Cynthia Glover, Colm Keane, Shingo Kihira,[...]. Blood 2015
183
13

Stromal gene signatures in large-B-cell lymphomas.
G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal,[...]. N Engl J Med 2008
12

Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.
Jihyun Kim, Junshik Hong, Seog Gyun Kim, Kyung Hoon Hwang, Minsu Kim, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin,[...]. Nucl Med Mol Imaging 2014
30
40

High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.
Dai Chihara, Yasuhiro Oki, Hiroshi Onoda, Hirofumi Taji, Kazuhito Yamamoto, Tsuneo Tamaki, Yasuo Morishima. Int J Hematol 2011
58
20

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
Peter Johnson, Massimo Federico, Amy Kirkwood, Alexander Fosså, Leanne Berkahn, Angelo Carella, Francesco d'Amore, Gunilla Enblad, Antonella Franceschetto, Michael Fulham,[...]. N Engl J Med 2016
408
12

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
12

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
11

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
Malik E Juweid, Sigrid Stroobants, Otto S Hoekstra, Felix M Mottaghy, Markus Dietlein, Ali Guermazi, Gregory A Wiseman, Lale Kostakoglu, Klemens Scheidhauer, Andreas Buck,[...]. J Clin Oncol 2007
974
11

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
Michael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, Max Wolf, Ruth Pettengell, Ingrid Vasova, Andrew Belch, Jan Walewski, Pier-Luigi Zinzani, Walter Mingrone,[...]. Lancet Oncol 2008
136
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.